The Official Journal of EuroPCR and the European Association of Percutaneous Coronary Interventions (EAPCI)

Interventions for valvular disease and heart failure

A novel implantable left atrial sensor for pressure monitoring in heart failure

EuroIntervention 2020;16:432-433. DOI: 10.4244/EIJ-D-19-00873

1. Structural Interventional Cardiology Division, University Hospital Careggi, Florence, Italy; 2. CardioVascular Center Frankfurt, Frankfurt am Main, Germany




Figure 1. The V-LAP technology. A) The V-LAP implant. B) The external unit. C) TEE image of the implanted V-LAP. D) Simultaneous V-LAP pressure tracings and pulmonary wedge pressure at the moment of the implantation.

Monitoring pressure and adapting therapy to the rapid changes of left ventricular loading conditions is the cornerstone of treatment of acute heart failure in hospitalised patients. This approach has also been translated into the chronic setting, as proved by the results of the only presently commercially available pulmonary pressure monitoring system (CardioMEMS™; Abbott Vascular, Santa Clara, CA, USA) in terms of hospital ...

Sign in to read and download the full article

Forgot your password?
No account yet? Sign up for free!
Create my pcr account

Join us for free and access thousands of articles from EuroIntervention, as well as presentations, videos, cases from PCRonline.com

Read next article
Pulmonary haemodynamic effects of interatrial shunt in heart failure with preserved ejection fraction: a preclinical study